Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome

Thomas M. Kaffenberger, Rajarsi Mandal, Barry M. Schaitkin, Barry E. Hirsch

Research output: Contribution to journalArticlepeer-review

Abstract

Objective tinnitus associated with eyelid closure is a rare clinical entity with only a few reported cases. This association previously was identified as forced eyelid closure syndrome (FECS) and involves an aberrant neural reflex between cranial nerve VII (activating the orbicularis oculi muscle) and cranial nerve V (activating the tensor tympani muscle). We present a 52-year-old Caucasian female with a 2-month history of FECS who was successfully treated with intrapalatal botulinum toxin, with full resolution of her objective tinnitus symptoms. This is the first reported use of botulinum toxin in FECS. Laryngoscope, 127:1199–1201, 2017.

Original languageEnglish (US)
Pages (from-to)1199-1201
Number of pages3
JournalLaryngoscope
Volume127
Issue number5
DOIs
StatePublished - May 1 2017
Externally publishedYes

Keywords

  • botulinum toxin
  • FECS
  • objective tinnitus
  • palatal tinnitus

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome'. Together they form a unique fingerprint.

Cite this